Sublingual and oral zolpidem for insomnia disorder: a 3-month randomized trial
Open Access
- 1 April 2020
- journal article
- research article
- Published by EDITORA SCIENTIFIC in Revista Brasileira de Psiquiatria
- Vol. 42 (2), 175-184
- https://doi.org/10.1590/1516-4446-2019-0389
Abstract
Objective: To evaluate the safety and efficacy of a 5 mg sublingual dose of zolpidem, compared to a 10 mg oral dose, at bedtime and "as needed" following middle-of-the-night awakenings. Methods: Participants were randomized into an oral group (oral zolpidem 10 mg and sublingual placebo at bedtime and "as-needed") and a sublingual group (oral placebo and sublingual zolpidem 5 mg at bedtime and "as-needed"). Participants underwent medical evaluation, polysomnography, the psychomotor vigilance test, and completed questionnaires. Results: Of 85 patients, 67 met the criteria for insomnia (48 +/- 10 years; 79% women) and were randomized. Of these, 46 completed 92 +/- 5 days of treatment. Mild-to-moderate adverse events were reported by 25% of the participants, including headache, sleepiness, and dizziness. Both treatments decreased middle-of-the-night awakenings by an average of -3.1 +/- 2.3 days/week and increased total sleep time by 1.5 hours. Changes in sleep quality and insomnia severity scores were also favorable and comparable between groups: variation depended on continuation of treatment. Regarding PSG findings, sleep latency decreased more in the sublingual group than the oral group (-14 +/- 42 vs. 10 +/- 29 min; p = 0.03). The psychomotor vigilance test showed minor residual effects 30 minutes after awakening, which reversed after 2 hours. Conclusions: The safety and efficacy of both zolpidem formulations are comparable. The sublingual 5 mg dose induced sleep more rapidly.Keywords
This publication has 31 references indexed in Scilit:
- Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tabletsThe Journal of Clinical Pharmacology, 2013
- Novel Sublingual Low-Dose Zolpidem Tablet Reduces Latency to Sleep Onset following Spontaneous Middle-of-the-Night Awakening in Insomnia in a Randomized, Double-Blind, Placebo-Controlled, Outpatient StudySleep, 2013
- Zolpidem for insomniaExpert Opinion on Pharmacotherapy, 2012
- Intention-to-treat concept: A reviewPerspectives in Clinical Research, 2011
- Night-to-night sleep variability in older adults with and without chronic insomniaSleep Medicine, 2010
- Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: A polysomnographic studySleep Medicine, 2009
- Cognitive Behavioral Therapy, Singly and Combined With Medication, for Persistent InsomniaJAMA, 2009
- Sleep Deprivation and Vigilant AttentionAnnals of the New York Academy of Sciences, 2008
- Variability and predictability in sleep patterns of chronic insomniacsJournal of Sleep Research, 2005
- The Pittsburgh sleep quality index: A new instrument for psychiatric practice and researchPsychiatry Research, 1989